BL
IMGN

Balentine LLC’s Immunogen Inc IMGN Stock Holding History

Balentine LLC’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-395
Closed -$2K – 886
2020
Q2 		$2K Buy
+395
New +$1.68K ﹤0.01% 875
2019
Q1 		– Sell
-554
Closed -$3K – 465
2018
Q4 		$3K Hold
554
– – ﹤0.01% 426
2018
Q3 		$5K Buy
+554
New +$5.33K ﹤0.01% 351
2018
Q1 		– Sell
-1,902
Closed -$12K – 549
2017
Q4 		$12K Hold
1,902
– – ﹤0.01% 450
2017
Q3 		$15K Sell
1,902
-2,339
-55% -$15.5K ﹤0.01% 425
2017
Q2 		$30K Hold
4,241
– – ﹤0.01% 313
2017
Q1 		$16K Hold
4,241
– – ﹤0.01% 378
2016
Q4 		$9K Hold
4,241
– – ﹤0.01% 419
2016
Q3 		$11K Buy
+4,241
New +$12.3K ﹤0.01% 356

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balentine LLC's IMGN Position: Q3 2020 in Review

Balentine LLC sold out of Immunogen Inc (IMGN) in Q3 2020, closing a stake of 395 shares — an estimated $2K sold.

Balentine LLC first reported a position in IMGN in Q3 2016 and held it in 9 quarters. The position peaked at $30K in Q2 2017. 185 funds tracked by Wall St. Rank hold IMGN as of Q3 2020.

  • Balentine LLC reported no remaining Immunogen Inc position as of Q3 2020 after selling out during the quarter.
  • Balentine LLC sold 395 Immunogen Inc shares in Q3 2020, an estimated $2K.
  • Balentine LLC first reported a position in Immunogen Inc in Q3 2016 and held it in 9 quarters.
  • Balentine LLC's Immunogen Inc position peaked at $30K in Q2 2017.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.